ArticleInternational journal of women's health2026
An Analysis of Trends in the Burden of Maternal Hemorrhage Attributable to Iron Deficiency in China from 1990 to 2023: A Population-Based Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study evaluated the burden of maternal hemorrhage (MH) attributable to iron deficiency in China from 1990 to 2023. Methods: This cross-sectional study utilized the data from the Global Burden of Disease (GBD) 2023 to analyze the disease burden associated with maternal hemorrhage attributable to iron deficiency in China. Joinpoint and age-period-cohort (APC) analysis were employed to assess the trend of the disease burden. Decomposition analysis was conducted to evaluate the unique contributions of changes in population age structure, population growth, and epidemiological trends to the disease burden trend. Results: From 1990 to 2023, the number of deaths and disability-adjusted life years (DALYs) of MH attributable to iron deficiency in China decreased from 2.08 to 0.03 (thousands) and 130.15 to 1.93 (thousands), respectively. The age-standardized disability-adjusted life years (ASDR) and age-standardized mortality rate (ASMR) decreased from 18.72 to 0.33 (per 100000 population) and from 0.30 to 0(per 100000 population), respectively. The ASMR and ASDR showed a downward trend (p < 0.001). The APC analysis showed that the mortality rate and DALYs rate first increased and then decreased with age. The mortality rate and DALYs rate decreased over time. The cohort effect showed that from the early birth cohort to the late birth cohort, the mortality rate and DALYs rate generally showed a downward trend. Decomposition analysis indicated that the changes in population age structure and epidemic trends had a significant impact on the decline in the mortality rate and DALYs rate. Conclusion: Although the overall disease burden of maternal hemorrhage attributable to iron deficiency in China has shown a downward trend, the disease situation remains severe. Iron deficiency among women of different age groups in China, especially those in the 20-39 age range, has led to a serious burden of maternal hemorrhage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.